检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:曹志刚[1] 王志红[1] 孙君重[1] 彭朝津[1] 冯少美 周晓燕[1] 杨清明[2]
机构地区:[1]解放军总医院第一附属医院老年肿瘤血液科,北京100853 [2]解放军总医院生物治疗病区
出 处:《中华血液学杂志》2015年第7期575-577,共3页Chinese Journal of Hematology
摘 要:目的 观察Brentuximab vedotin (BV)联合盐酸氮芥治疗复发难治性经典型霍奇金淋巴瘤(cHL)患者的疗效及不良反应.方法 对6例BV单药治疗失败后cHL患者给予BV联合盐酸氮芥治疗,具体用药:BV 1.2~1.8 mg/kg第1天静脉滴注,盐酸氮芥6 mg/m2第1天静脉滴注,每21d为1个疗程,中位疗程数为4(3~8)个.治疗后每2个疗程行CT检查,每4个疗程行PET-CT检查,每个疗程前行血常规和生化检查,评价临床疗效与不良反应.结果 6例患者中男4例,女2例,中位年龄20.5(17~26)岁;2例为BV治疗达完全缓解后复发,4例为BV治疗后病情稳定.中位观察时间为15(11~25)周.6例患者接受BV联合盐酸氮芥治疗后2例获得完全缓解,4例获得部分缓解,总有效率为100%.4例患者出现骨髓抑制(Ⅰ度2例,Ⅳ度2例);2例出现Ⅱ度胃肠道反应;1例出现Ⅰ度肝损伤,心肌酶增高;1例出现Ⅰ度口腔溃疡.不良反应可耐受或对症处理后症状缓解,未影响患者治疗.结论 BV联合盐酸氮芥治疗BV单药治疗失败后复发难治性cHL,疗效显著,不良反应可耐受.Objective To observe the clinical efficacy and side effects of brentuximab vedotin (BV) plus chlormethine hydrochloride (CH)in patients with relapsed and refractory Hodgkin lymphoma (HL)after failure with BV alone.Methods From March,2014 to December,2014,6 patients who failed with BV monotherapy were enrolled in this study.The chemotherapy regimen consisted of BV (1.2-1.8 mg/kg,iv.gtt,d1)and CH (6 mg/m2,iv.gtt,d1)was given for 3 weeks as one course,and all patients received about 3-8 courses of chemotherapy,with an median of 4 courses.Clinical efficacy and adverse events were assessed and observed by radiographic examination and serological detection.Results Among 6 patients,the overall response rate was 100% with 2 complete remissionand 4 partial remission.The main adverse events were grade Ⅰ (2 patients)and Ⅳ (2 patients)bone marrow depression,grade Ⅱ (2patients)gastrointestinal reaction,grade Ⅰ (1 patient)increase oftransaminase and myocardial enzymc and grade Ⅰ (1 patient)mouth ulcers.Conclusion The combination of BV and CH in the treatment of relapsed and refractory HL after failure with BV alone was high effective and the toxicities were well tolerable.
关 键 词:霍奇金病 氮芥 治疗结果 Brentuximab vedotin
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:18.191.187.74